Psilocybin, the active ingredient in “magic” mushrooms, has shown promise for treating anxiety in terminal cancer patients, easing symptoms of obsessive-compulsive disorder, reducing the distress associated with social exclusion and making it easier to quit smoking. New work suggests it may also help people with treatment-resistant depression. In a study published May 17 in The Lancet…

(Photo credit: afgooey74, CC)

Leave a Reply